US2390529A
(en)
|
1942-02-03 |
1945-12-11 |
Ernst A H Friedheim |
Hydrazino-1,3,5-triazino derivatives of substituted phenylarsenic compounds
|
US2913408A
(en)
|
1956-12-28 |
1959-11-17 |
Dow Chemical Co |
Corrosion inhibitors for ferrous metals in aqueous solutions of non-oxidizing acids
|
DE1252823B
(ro)
|
1963-02-15 |
|
|
|
BE754242A
(fr)
|
1970-07-15 |
1971-02-01 |
Geigy Ag J R |
Diamino-s-triazines et dinitro-s-triazines
|
US3867383A
(en)
|
1971-03-29 |
1975-02-18 |
Ciba Geigy Corp |
Monoanthranilatoanilino-s-triazines
|
BE793501A
(fr)
|
1971-12-31 |
1973-06-29 |
Ciba Geigy |
Composes heterocycliques et produits phytopharmaceutiques qui en contiennent
|
CH606334A5
(ro)
|
1974-06-21 |
1978-10-31 |
Ciba Geigy Ag |
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
JPS58186682A
(ja)
|
1982-04-27 |
1983-10-31 |
日本化薬株式会社 |
セルロ−ス又はセルロ−ス含有繊維材料の染色法
|
JPS59151784U
(ja)
|
1983-03-30 |
1984-10-11 |
日産自動車株式会社 |
トラツクのリヤボデイ構造
|
DE3512630A1
(de)
|
1985-04-06 |
1986-10-23 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zum faerben oder bedrucken von cellulosefasern oder cellulosemischfasern
|
US5041443A
(en)
|
1989-02-21 |
1991-08-20 |
Dainippon Pharmaceutical Co., Ltd. |
Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
|
US5021421A
(en)
|
1989-03-03 |
1991-06-04 |
Dainippon Pharmaceutical Co., Ltd. |
2-(1-Piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
|
JPH0499768A
(ja)
|
1990-08-17 |
1992-03-31 |
Dainippon Pharmaceut Co Ltd |
4―(4―フェニルピリジン―2―イル)ピペラジン―1―オキシド誘導体
|
JPH05140126A
(ja)
|
1991-11-26 |
1993-06-08 |
Hokko Chem Ind Co Ltd |
トリアゾール誘導体および除草剤
|
DE69322076D1
(de)
|
1992-02-28 |
1998-12-17 |
Zenyaku Kogyo Kk |
S-triazin-derivate und diese als aktiven wirkstoff enthaltende heilmittel gegen östrogen abhängige krankheiten
|
IL115420A0
(en)
|
1994-09-26 |
1995-12-31 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
WO1998021191A1
(fr)
|
1995-05-16 |
1998-05-22 |
Nissan Chemical Industries, Ltd. |
Derives de cyanoethylmelamine et procede de production
|
FR2735127B1
(fr)
|
1995-06-09 |
1997-08-22 |
Pf Medicament |
Nouvelles piperazines heteroaromatiques utiles comme medicaments.
|
ES2100129B1
(es)
|
1995-10-11 |
1998-02-16 |
Medichem Sa |
Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
WO1997028128A1
(en)
|
1996-02-02 |
1997-08-07 |
Zeneca Limited |
Heterocyclic compounds useful as pharmaceutical agents
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
JPH09291034A
(ja)
|
1996-02-27 |
1997-11-11 |
Yoshitomi Pharmaceut Ind Ltd |
縮合ピリジン化合物およびその医薬としての用途
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US5834485A
(en)
|
1996-05-20 |
1998-11-10 |
Chiroscience Limited |
Quinoline sulfonamides and their therapeutic use
|
US5984882A
(en)
|
1996-08-19 |
1999-11-16 |
Angiosonics Inc. |
Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
|
US6399358B1
(en)
|
1997-03-31 |
2002-06-04 |
Thomas Jefferson University |
Human gene encoding human chondroitin 6-sulfotransferase
|
ATE302597T1
(de)
|
1997-06-06 |
2005-09-15 |
Depomed Inc |
Im magen verweilende orale dosierungsformen von wasserlöslichen arzneistoffen mit kontrollierter freisetzung
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
DK0901786T3
(da)
|
1997-08-11 |
2007-10-08 |
Pfizer Prod Inc |
Faste farmaceutiske dispersioner med foröget biotilgængelighed
|
JPH11158073A
(ja)
|
1997-09-26 |
1999-06-15 |
Takeda Chem Ind Ltd |
アデノシンa3拮抗剤
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
ATE297383T1
(de)
|
1997-12-22 |
2005-06-15 |
Bayer Pharmaceuticals Corp |
Hemmung der p38 kinase unter verwendung von symmetrischen und asymmetrischen diphenylharnstoffen
|
WO2000002864A1
(en)
|
1998-07-10 |
2000-01-20 |
Martens Juergen |
Precusors for pna-monomers
|
US6783965B1
(en)
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
ES2245114T3
(es)
|
1998-08-06 |
2005-12-16 |
Mountain View Pharmaceuticals, Inc. |
Conjugados de peg-oxidasa de urato y su uso.
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
WO2000075129A1
(en)
|
1999-06-07 |
2000-12-14 |
Shire Biochem Inc. |
Thiophene integrin inhibitors
|
DE60023920T2
(de)
|
1999-08-27 |
2006-07-20 |
Sugen, Inc., South San Francisco |
Phosphatmimetika und Verfahren zur Behandlung mit Phosphataseinhibitoren HIBITOREN
|
IL148698A0
(en)
|
1999-09-17 |
2002-09-12 |
Cor Therapeutics Inc |
INHIBITORS OF FACTOR Xa
|
MX226123B
(es)
|
1999-09-17 |
2005-02-07 |
Millennium Pharm Inc |
Benzamidas e inhibidores del factor xa relacionadas.
|
EP1246823A1
(en)
|
1999-12-28 |
2002-10-09 |
Pharmacopeia, Inc. |
Pyrimidine and triazine kinase inhibitors
|
ATE340563T1
(de)
|
2000-02-04 |
2006-10-15 |
Depomed Inc |
DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT
|
US6376515B2
(en)
|
2000-02-29 |
2002-04-23 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor Xa
|
US6723730B2
(en)
|
2000-07-20 |
2004-04-20 |
Neurogen Corporation |
Capsaicin receptor ligands
|
JP4113323B2
(ja)
|
2000-08-07 |
2008-07-09 |
富士フイルム株式会社 |
アゾ色素及びそれを含むインクジェット記録用インク、並びにインクジェット記録方法
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
WO2002088101A2
(en)
|
2001-04-27 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of bace
|
EP1412325A1
(en)
|
2001-06-11 |
2004-04-28 |
Biovitrum Ab |
Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
|
JP2005500294A
(ja)
|
2001-06-19 |
2005-01-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
ホスホジエステラーゼ7に対するピリミジン阻害剤
|
DE60238066D1
(de)
|
2001-08-17 |
2010-12-02 |
Basf Se |
Triazinderivate und deren verwendung als sonnenschutzmittel
|
JP4753336B2
(ja)
|
2001-09-04 |
2011-08-24 |
日本化薬株式会社 |
新規アリル化合物及びその製法
|
US6723340B2
(en)
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
US6878196B2
(en)
|
2002-01-15 |
2005-04-12 |
Fuji Photo Film Co., Ltd. |
Ink, ink jet recording method and azo compound
|
US20040067234A1
(en)
|
2002-07-11 |
2004-04-08 |
Paz Einat |
Isocitrate dehydrogenase and uses thereof
|
SI2256108T1
(sl)
|
2002-07-18 |
2016-05-31 |
Janssen Pharmaceutica N.V. |
Substituirani triazinski kinazni inhibitorji
|
JP2004083610A
(ja)
|
2002-08-22 |
2004-03-18 |
Fuji Photo Film Co Ltd |
インクセット、インクカートリッジ、記録方法、プリンター及び記録物
|
JP2004107220A
(ja)
|
2002-09-13 |
2004-04-08 |
Mitsubishi Pharma Corp |
TNF−α産生抑制剤
|
AR042052A1
(es)
|
2002-11-15 |
2005-06-08 |
Vertex Pharma |
Diaminotriazoles utiles como inhibidores de proteinquinasas
|
AU2003293333A1
(en)
|
2002-12-02 |
2004-06-23 |
Arqule, Inc. |
Method of treating cancers
|
EP1590364B1
(en)
|
2002-12-16 |
2011-10-05 |
Genmab A/S |
Human monoclonal antibodies against interleukin 8 (il-8)
|
MXPA05007382A
(es)
|
2003-01-10 |
2005-11-23 |
Threshold Pharmaceuticals Inc |
Tratamiento de cancer con 2-desoxiglucosa.
|
US7358262B2
(en)
|
2003-01-29 |
2008-04-15 |
Whitehead Institute For Biomedical Research |
Identification of genotype-selective anti-tumor agents
|
WO2004073619A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
US7038038B2
(en)
|
2003-03-17 |
2006-05-02 |
Pharmion Corporation |
Synthesis of 5-azacytidine
|
US6887855B2
(en)
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
US6943249B2
(en)
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
EP1615698B1
(en)
|
2003-04-11 |
2010-09-29 |
High Point Pharmaceuticals, LLC |
New amide derivatives and pharmaceutical use thereof
|
EP1482418A1
(en)
|
2003-05-28 |
2004-12-01 |
Sap Ag |
A data processing method and system
|
CA2534921C
(en)
|
2003-08-06 |
2011-06-14 |
Vertex Pharmaceuticals Incorporated |
Aminotriazole compounds useful as inhibitors of protein kinases
|
EP1689722A2
(en)
|
2003-10-10 |
2006-08-16 |
Bayer Pharmaceuticals Corporation |
4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
|
US20070196395A1
(en)
|
2003-12-12 |
2007-08-23 |
Mackerell Alexander |
Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
|
CA2551524A1
(en)
|
2003-12-24 |
2005-07-21 |
Scios, Inc. |
Treatment of malignant gliomas with tgf-beta inhibitors
|
JP2005264016A
(ja)
|
2004-03-19 |
2005-09-29 |
Fuji Photo Film Co Ltd |
インクジェット記録用インク、インクセット及びインクジェット記録方法
|
US7335770B2
(en)
|
2004-03-24 |
2008-02-26 |
Reddy U5 Therapeutics, Inc. |
Triazine compounds and their analogs, compositions, and methods
|
US7192781B2
(en)
|
2004-04-13 |
2007-03-20 |
Pharmion Corporation |
Methods for stabilizing 5-azacytidine in plasma
|
GB0412526D0
(en)
|
2004-06-05 |
2004-07-14 |
Leuven K U Res & Dev |
Type 2 diabetes
|
CA2580845A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
AU2005286593A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyridine compounds, process for their preparation and compositions containing them
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
US20100160324A1
(en)
|
2004-12-30 |
2010-06-24 |
Astex Therapeutics Limited |
Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
|
BRPI0606930A2
(pt)
|
2005-01-25 |
2009-12-01 |
Astrazeneca Ab |
composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo, e, métodos para a produção de um efeito de inibição de b-raf em um animal de sangue quente, para a produção de um efeito anti-cáncer em um animal de sangue quente e para o tratamento de doenças de um animal em um animal de sangue quente
|
CN101194016B
(zh)
|
2005-04-11 |
2012-09-05 |
萨文特医药公司 |
尿酸氧化酶的变体形式及其用途
|
WO2006133420A2
(en)
|
2005-06-08 |
2006-12-14 |
Millennium Pharmaceuticals, Inc. |
Treatment of patients with cancer therapy
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
BRPI0615233A2
(pt)
|
2005-08-26 |
2011-05-10 |
Serono Lab |
derivados de pirazina e uso dos mesmos como inibidores p13k
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
TW200815426A
(en)
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
US8343548B2
(en)
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
WO2008036835A2
(en)
|
2006-09-20 |
2008-03-27 |
Reddy Us Therapeutics |
Methods and compositions for upregulation of peroxiredoxin activity
|
US20080109846A1
(en)
|
2006-10-23 |
2008-05-08 |
Ewertz C Christian |
System and method for audiovisual content playback
|
JP2010508300A
(ja)
|
2006-10-26 |
2010-03-18 |
フライン、ギャリー・エー. |
アクアポリン修飾因子並びに浮腫および体液平衡異常の治療のためのそれらの使用方法
|
HUP0600810A3
(en)
|
2006-10-27 |
2008-09-29 |
Richter Gedeon Nyrt |
New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
CN101679371A
(zh)
|
2006-12-04 |
2010-03-24 |
艾美罗股份公司 |
作为腺苷受体拮抗剂的取代的嘧啶
|
WO2008073670A2
(en)
|
2006-12-08 |
2008-06-19 |
Millennium Pharmaceuticals, Inc. |
Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
|
US7858782B2
(en)
|
2006-12-15 |
2010-12-28 |
Abraxis Bioscience, Llc |
Triazine derivatives and their therapeutical applications
|
WO2008131547A1
(en)
|
2007-04-30 |
2008-11-06 |
Prometic Biosciences Inc. |
'triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives'
|
US20090029992A1
(en)
|
2007-06-11 |
2009-01-29 |
Agoston Gregory E |
Substituted pyrazole compounds
|
CN103923072B
(zh)
|
2007-07-20 |
2017-05-31 |
内尔维阿诺医学科学有限公司 |
作为具有激酶抑制剂活性的取代的吲唑衍生物
|
US8415340B2
(en)
|
2007-07-25 |
2013-04-09 |
Bristol-Myers Squibb Company |
Triazine kinase inhibitors
|
TW200906818A
(en)
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
TW200924778A
(en)
|
2007-10-10 |
2009-06-16 |
Takeda Pharmaceutical |
Amide compound
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
JP5277685B2
(ja)
|
2008-03-26 |
2013-08-28 |
富士ゼロックス株式会社 |
電子写真感光体、画像形成装置、プロセスカートリッジ及び画像形成方法
|
GB0805477D0
(en)
|
2008-03-26 |
2008-04-30 |
Univ Nottingham |
Pyrimidines triazines and their use as pharmaceutical agents
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
CN101575408B
(zh)
|
2008-05-09 |
2013-10-30 |
Mca技术有限公司 |
用作阻燃剂和光稳定剂的聚三嗪基化合物
|
AU2009246926B2
(en)
*
|
2008-05-15 |
2014-06-26 |
Celgene Corporation |
Oral formulations of cytidine analogs and methods of use thereof
|
FR2932483A1
(fr)
|
2008-06-13 |
2009-12-18 |
Cytomics Systems |
Composes utiles pour le traitement des cancers.
|
TW201028381A
(en)
|
2008-07-14 |
2010-08-01 |
Shionogi & Co |
Pyridine derivative having ttk inhibition activity
|
US20100144722A1
(en)
|
2008-09-03 |
2010-06-10 |
Dr. Reddy's Laboratories Ltd. |
Novel heterocyclic compounds as gata modulators
|
WO2010028099A1
(en)
|
2008-09-03 |
2010-03-11 |
The Johns Hopkins University |
Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
|
JP2010079130A
(ja)
|
2008-09-29 |
2010-04-08 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
EP2370417A2
(en)
|
2008-11-21 |
2011-10-05 |
Millennium Pharmaceuticals, Inc. |
Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
|
JP2010181540A
(ja)
|
2009-02-04 |
2010-08-19 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
AU2010211672B2
(en)
|
2009-02-06 |
2016-08-04 |
Nippon Shinyaku Co., Ltd. |
Aminopyrazine derivative and medicine
|
AU2010223919B2
(en)
|
2009-03-13 |
2016-03-31 |
Les Laboratoires Servier |
Methods and compositions for cell-proliferation-related disorders
|
ES2619557T3
(es)
|
2009-05-04 |
2017-06-26 |
Agios Pharmaceuticals, Inc. |
Activadores de PKM2 para uso en el tratamiento del cáncer
|
WO2010130638A1
(en)
|
2009-05-14 |
2010-11-18 |
Evotec Ag |
Sulfonamide compounds, pharmaceutical compositions and uses thereof
|
WO2010144338A1
(en)
|
2009-06-08 |
2010-12-16 |
Abraxis Bioscience, Llc |
Triazine derivatives and their therapeutical applications
|
AU2010258974A1
(en)
|
2009-06-09 |
2012-01-12 |
California Capital Equity, Llc |
Pyridil-triazine inhibitors of hedgehog signaling
|
WO2010144522A1
(en)
|
2009-06-09 |
2010-12-16 |
Abraxis Bioscience, Llc |
Ureidophenyl substituted triazine derivatives and their therapeutical applications
|
UA107667C2
(uk)
|
2009-06-29 |
2015-02-10 |
Аджиос Фармасьютікалз, Інк. |
Лікарські сполуки, що модулюють активність піруваткінази-м2, композиції на їх основі та застосування при лікуванні раку
|
WO2011005208A1
(en)
|
2009-07-10 |
2011-01-13 |
Milux Holding S.A. |
Knee joint device and method
|
WO2011027249A2
(en)
|
2009-09-01 |
2011-03-10 |
Pfizer Inc. |
Benzimidazole derivatives
|
WO2011032169A2
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
JP5473851B2
(ja)
|
2009-09-30 |
2014-04-16 |
富士フイルム株式会社 |
高分子フィルム、位相差フィルム、偏光板及び液晶表示装置
|
US8652534B2
(en)
|
2009-10-14 |
2014-02-18 |
Berry Pharmaceuticals, LLC |
Compositions and methods for treatment of mammalian skin
|
WO2011050210A1
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
US9062076B2
(en)
|
2009-10-22 |
2015-06-23 |
Fibrotech Therapeutics Pty Ltd |
Fused ring analogues of anti-fibrotic agents
|
ES2642109T3
(es)
|
2009-12-09 |
2017-11-15 |
Agios Pharmaceuticals, Inc. |
Compuestos terapéuticamente activos para su uso en el tratamiento de cáncer caracterizados por tener una mutación de IDH
|
NZ578968A
(en)
|
2010-02-10 |
2011-03-31 |
Allans Sheetmetal And Engineering Services |
Fuel feed system for a pellet fire
|
WO2011123618A1
(en)
|
2010-04-01 |
2011-10-06 |
Agios Pharmaceuticals, Inc. |
Methods of identifying a candidate compound
|
US20130109643A1
(en)
|
2010-05-10 |
2013-05-02 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
US10064885B2
(en)
|
2010-07-09 |
2018-09-04 |
Massachusetts Institute Of Technology |
Metabolic gene, enzyme, and flux targets for cancer therapy
|
ES2704862T3
(es)
|
2010-07-16 |
2019-03-20 |
Agios Pharmaceuticals Inc |
Composiciones terapéuticamente activas y su método de uso
|
PT2630146T
(pt)
|
2010-10-21 |
2020-07-20 |
Medivation Tech Llc |
Sal tosilato de (8s,9r)-5-fluoro-8-(4-fluorofenil)-9-(1-metil-1h-1,2,4-triazol-5-il)-8,9-di-hidro-2h-pirido[4,3,2-de]ftalazin-3(7h)-ona cristalino
|
WO2012078288A2
(en)
|
2010-11-08 |
2012-06-14 |
Washington University |
Methods of determining risk of adverse outcomes in acute myeloid leukemia
|
KR20140049961A
(ko)
|
2010-11-29 |
2014-04-28 |
갈레온 파마슈티칼스, 인코포레이티드 |
호흡 조절 장애 또는 질병의 치료를 위한 호흡 자극제로서의 신규 화합물
|
TWI549947B
(zh)
|
2010-12-29 |
2016-09-21 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
WO2012106299A1
(en)
|
2011-01-31 |
2012-08-09 |
Celgene Corporation |
Pharmaceutical compositions of cytidine analogs and methods of use thereof
|
EP2691391A4
(en)
|
2011-03-29 |
2014-09-10 |
Broad Inst Inc |
COMPOUNDS AND METHODS FOR THE TREATMENT OF DISEASES RELATED TO ISOCITRATE DEHYDROGENASE
|
WO2012151452A1
(en)
|
2011-05-03 |
2012-11-08 |
Agios Pharmaceuticals, Inc |
Pyruvate kinase activators for use in therapy
|
TWI555737B
(zh)
|
2011-05-24 |
2016-11-01 |
拜耳知識產權公司 |
含有硫醯亞胺基團之4-芳基-n-苯基-1,3,5-三氮雜苯-2-胺
|
AU2012268619B2
(en)
|
2011-06-06 |
2017-08-17 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of isocitrate dehydrogenase (IDH1) gene expression
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
WO2013004332A1
(en)
|
2011-07-07 |
2013-01-10 |
Merck Patent Gmbh |
Substituted azaheterocycles for the treatment of cancer
|
ES2627120T3
(es)
|
2011-07-08 |
2017-07-26 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Medicamento para el tratamiento del cáncer de hígado
|
AU2012287103B2
(en)
|
2011-07-22 |
2017-03-30 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
CN102659765B
(zh)
|
2011-12-31 |
2014-09-10 |
沈阳药科大学 |
嘧啶及三嗪类化合物的制备方法和应用
|
KR101893112B1
(ko)
|
2012-01-06 |
2018-08-30 |
아지오스 파마슈티컬스 아이엔씨. |
치료학적으로 활성인 화합물 및 이의 이용 방법
|
EP2804850B1
(en)
|
2012-01-19 |
2018-08-29 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
EP2634259A1
(en)
|
2012-03-01 |
2013-09-04 |
Deutsches Krebsforschungszentrum |
Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG)
|
CN104169260A
(zh)
|
2012-03-09 |
2014-11-26 |
卡尔那生物科学株式会社 |
新三嗪衍生物
|
AU2013232379A1
(en)
|
2012-03-12 |
2014-09-25 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia
|
WO2014015422A1
(en)
|
2012-07-27 |
2014-01-30 |
Ontario Institute For Cancer Research |
Cellulose-based nanoparticles for drug delivery
|
WO2014062511A1
(en)
|
2012-10-15 |
2014-04-24 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
WO2015127173A1
(en)
|
2014-02-20 |
2015-08-27 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
WO2015127172A1
(en)
|
2014-02-20 |
2015-08-27 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
LT3116491T
(lt)
|
2014-03-14 |
2021-08-10 |
Les Laboratoires Servier Sas |
Terapiškai aktyvių junginių farmacinės kompozicijos
|
AU2015229214B2
(en)
|
2014-03-14 |
2019-07-11 |
Les Laboratoires Servier |
Pharmaceutical compositions of therapeutically active compounds
|
SG11201803088PA
(en)
|
2015-10-15 |
2018-05-30 |
Agios Pharmaceuticals Inc |
Combination therapy for treating malignancies
|
WO2017066611A1
(en)
*
|
2015-10-15 |
2017-04-20 |
Celgene Corporation |
Combination therapy for treating malignancies
|
DK3362066T3
(da)
|
2015-10-15 |
2021-11-22 |
Les Laboratoires Servier Sas |
Kombinationsterapi til behandling af maligniteter
|
AU2016363011B2
(en)
|
2015-12-04 |
2022-07-14 |
Les Laboratoires Servier |
Methods of treatment of malignancies
|
EP3419593B1
(en)
|
2016-02-26 |
2022-03-23 |
Celgene Corporation |
Enasidenib for use in the treatment of relapsed or refractory acute myeloid leukaemia
|
EP3512519A1
(en)
*
|
2016-09-14 |
2019-07-24 |
Gilead Sciences, Inc. |
Syk inhibitors
|